TITLE

Implications of Anemia in Human Immunodeficiency Virus, Cancer, and Hepatitis C Virus

AUTHOR(S)
Mildvan, Donna
PUB. DATE
November 2003
SOURCE
Clinical Infectious Diseases;11/15/2003 Supplement, Vol. 37, pS293
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Anemia is a multifactorial problem in patients with human immunodeficiency virus (HIV) infection, cancer, and hepatitis C virus (HCV) infection. New insights regarding anemia symptoms and quality of life (QOL) have prompted reassessment of traditional triggers for anemia treatment to increase hemoglobin (Hb) and improve QOL. In HIV-positive patients, anemia is independently associated with disease progression and survival. Many HIV-positive patients receiving highly active antiretroviral therapy (HAART) still develop mild to moderate anemia and associated QOL impairment. Epoetin alfa effectively increases Hb and improves QOL in these patients. Many HIV-positive patients are coinfected with HCV. Standard HCV therapy (interferon alfa/ribavirin) can cause anemia that may result in treatment alterations and compromised virologic outcome. Epoetin alfa therapy in anemic HCV patients increases Hb levels and may provide other benefits. Neuroprotective effects of epoetin alfa in preclinical models of central nervous system disorders have recently been demonstrated, implying a new therapeutic role for this cytokine.
ACCESSION #
11472160

 

Related Articles

  • Review of the Effect of Highly Active Antiretroviral Therapy on Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus and HCV Coinfection. Cooper, Curtis L.; Cameron, D. William // Clinical Infectious Diseases;10/1/2002, Vol. 35 Issue 7, p873 

    Describes the apparent effect of antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection. Systematic and biologic variation of HCV RNA level.

  • Liver Damage and Kinetics of Hepatitis C Virus and Human Immunodeficiency Virus Replication during the Early Phases of Combination Antiretroviral Treatment. Puoti, Massimo; Gargiulo, Francesco; Roldan, Eugenia Quiros; Chiodera, Alessandro; Palvarini, Loredana; Spinetti, Angiola; Zaltron, Serena; Putzolu, Valeria; Zanini, Barbara; Favilli, Flavia; Turano, Adolfo; Carosi, Giampiero // Journal of Infectious Diseases;6/1/2000, Vol. 181 Issue 6, p2033 

    Assesses the liver damage and kinetics of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) replication during the early phases of combination antiretroviral treatment. Evolution of HCV RNA, HIV RNA, CD4 and CD8 cell counts and alanine aminotransferase levels during combination...

  • Hepatitis C in the Setting of HIV. Laurence, Jeffrey // AIDS Patient Care & STDs;Aug98, Vol. 12 Issue 8, p595 

    Editorial. Discusses the special character of hepatitis C virus (HCV) disease in the setting of human immunodeficiency virus (HIV). Etiologic link between HCV and several serious diseases; Classification of HCV; Symptoms of HCV infection; Information on the management of HCV; Recommendation...

  • HAART AND HCV INFECTION.  // AIDS Patient Care & STDs;Aug98, Vol. 12 Issue 8, p646 

    Reports that a study found that highly active antiretroviral therapy (HAART) does not affect hepatitis C virus (HCV) progression in patients who have coinfection with the human immunodeficiency virus (HIV) and HCV. Who monitored HCV progression in 22 patients; Information on study.

  • Frequencies of HBV, HCV, HIV, and Syphilis Markers Among Blood Donors: A Hospital-Based Study in Hodeidah, Yemen. Mohammed Saghir, Sultan Ayesh; Al-Hassan, Faisal Muti; Ali Alsalahi, Omar Saeed; Abdul-Alaziz, Abdullah Ebrahim; Baqir, Huda Salman // Tropical Journal of Pharmaceutical Research;Feb2012, Vol. 11 Issue 1, p132 

    Purpose: This study aimed to determine the frequency rates of human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV), and syphilis among blood donors. Methods: Physically fit persons aged 18 - 48 years who came for blood donation at the blood bank unit of the...

  • Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies. Volberding, Paul A.; Levine, Alexandra M.; Dieterich, Douglas; Mildvan, Donna; Mitsuyasu, Ronald; Saag, Michael // Clinical Infectious Diseases;5/15/2004, Vol. 38 Issue 10, p1454 

    Anemia in human immunodeficiency virus (HIV)-infected patients can have serious implications, which vary from functional and quality-of-life decrements to an association with disease progression and decreased survival. In 2002, 16 members of the Anemia in HIV Working Group, an expert panel of...

  • Epoetin alfa adds colour in HIV/hep C.  // PharmacoEconomics & Outcomes News;8/27/2005, Issue 485, p12 

    Discusses research being done on the effectiveness of epoetin alfa in improving anemia in HIV/hepatitis C virus-coinfected patients. Reference to a study by M. S. Sulkowski and colleagues, published in the August 2005 issue of the "Journal of Acquired Immune Deficiency Syndromes."

  • HIV/Hepatitis C Virus–Coinfected Patients and Cirrhosis: How to Diagnose It and What to Do Next? Martel-Laferrière, Valérie; Wong, Michael; Dieterich, Douglas T. // Clinical Infectious Diseases;Mar2014, Vol. 58 Issue 6, p840 

    Cirrhosis is a major health problem in HIV/hepatitis C virus–coinfected patients. Making the diagnosis is challenging but it is imperative to screen for complications and adjust treatment accordingly. Noninvasive tests can help the infectious disease specialist to diagnose cirrhosis.Liver...

  • Preliminary study on effect of hepatitis C virus nonstructural protein 5A on HIV LTR. PENG Milin; XIAO Xinqiang; JIANG Yongfang // Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi;2014, Vol. 30 Issue 2, p136 

    To investigate the effect of nonstructural protein 5A (NS5A) encoded by the human hepatitis C virus (HCV) RNA genome on human immunodeficiency virus (HIV) long terminal repeat (LTR) and to provide an experimental basis for the study on the effect of HCV on HIV. Methods Hepatocellular carcinoma...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics